Sedana Medical publishes prospectus and certain new financial information in connection with the listing change to Nasdaq Stockholm
Sedana Medical AB (publ) (the "Company" or "Sedana Medical") announced on 19 January 2023 that Nasdaq Stockholm's listing committee had approved the Company's application for admission to trading of the Company's shares on Nasdaq Stockholm. The Company has prepared a prospectus in connection with the listing change, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) (the "Prospectus"). The Prospectus (only in Swedish) is available on the Company's website.Publication of the Prospectus For complete information about the listing change,